Affimed in the spotlight (part VI)
Evaluating AFM13+NK cells data and expectations for upcoming call
Boutique Biotech has been following Affimed (AFMD) in five previous posts. Last month, Affimed reported surprise data for AFM13+NK cells with partner MD Anderson. This is the data that was expected in mid-December, which now the company will host an event on December 9th at 8:30am to review. All in all, the data was very promising.
The Data Reported
As of…